OraSure Technologies, Inc. (OSUR) Shares Sold by State of Tennessee Treasury Department

State of Tennessee Treasury Department reduced its position in OraSure Technologies, Inc. (NASDAQ:OSUR) by 5.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,332 shares of the medical instruments supplier’s stock after selling 3,118 shares during the period. State of Tennessee Treasury Department owned approximately 0.08% of OraSure Technologies worth $1,110,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Chicago Equity Partners LLC raised its holdings in shares of OraSure Technologies by 53.5% during the 3rd quarter. Chicago Equity Partners LLC now owns 120,355 shares of the medical instruments supplier’s stock valued at $2,708,000 after buying an additional 41,925 shares during the period. ARP Americas LLC purchased a new stake in shares of OraSure Technologies during the 3rd quarter valued at about $221,000. Crossmark Global Holdings Inc. purchased a new stake in shares of OraSure Technologies during the 3rd quarter valued at about $750,000. Raymond James Financial Services Advisors Inc. raised its holdings in shares of OraSure Technologies by 15.5% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 36,026 shares of the medical instruments supplier’s stock valued at $811,000 after buying an additional 4,825 shares during the period. Finally, LS Investment Advisors LLC raised its holdings in shares of OraSure Technologies by 35.5% during the 3rd quarter. LS Investment Advisors LLC now owns 17,357 shares of the medical instruments supplier’s stock valued at $391,000 after buying an additional 4,544 shares during the period. 94.41% of the stock is currently owned by institutional investors and hedge funds.

Shares of OraSure Technologies, Inc. (OSUR) opened at $16.38 on Friday. OraSure Technologies, Inc. has a twelve month low of $8.21 and a twelve month high of $23.01. The stock has a market capitalization of $1,022.53, a P/E ratio of 32.42, a price-to-earnings-growth ratio of 3.24 and a beta of 1.39.

OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings data on Wednesday, November 1st. The medical instruments supplier reported $0.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.09. OraSure Technologies had a return on equity of 14.12% and a net margin of 20.48%. The company had revenue of $42.30 million for the quarter, compared to the consensus estimate of $40.87 million. During the same period in the previous year, the business earned $0.11 EPS. OraSure Technologies’s revenue for the quarter was up 31.0% compared to the same quarter last year. analysts forecast that OraSure Technologies, Inc. will post 0.42 EPS for the current year.

In other OraSure Technologies news, CEO Douglas A. Michels sold 25,000 shares of OraSure Technologies stock in a transaction that occurred on Friday, September 29th. The stock was sold at an average price of $22.55, for a total transaction of $563,750.00. Following the sale, the chief executive officer now directly owns 743,058 shares in the company, valued at approximately $16,755,957.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Brian Smith sold 9,112 shares of OraSure Technologies stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $20.47, for a total value of $186,522.64. Following the sale, the insider now owns 32,477 shares in the company, valued at $664,804.19. The disclosure for this sale can be found here. Insiders have sold a total of 58,035 shares of company stock worth $1,297,612 over the last 90 days. 6.40% of the stock is owned by company insiders.

Several equities research analysts recently commented on the company. Zacks Investment Research downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a report on Wednesday, October 4th. Jefferies Group LLC reiterated a “buy” rating and set a $20.00 target price on shares of OraSure Technologies in a report on Tuesday, September 12th. Canaccord Genuity reiterated a “buy” rating and set a $22.00 target price on shares of OraSure Technologies in a report on Tuesday, September 19th. Finally, BidaskClub downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $18.21.

COPYRIGHT VIOLATION WARNING: This article was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.chaffeybreeze.com/2017/11/25/orasure-technologies-inc-osur-shares-sold-by-state-of-tennessee-treasury-department.html.

OraSure Technologies Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply